info@RegenProtocols.com
561-325-7000
141 NW 20th St., Suite G1 Boca Raton, FL 33431
A multi-step protocol that pairs regenerative peptides with growth hormone secretagogues to rebuild the connective tissue behind skin, hair, and nails.
This protocol takes a multimodal pharmacological approach to age-related breakdown of the integumentary system. By pairing regenerative signaling peptides with growth hormone secretagogues, it aims to restore the structural integrity of the extracellular matrix (ECM) at the systemic level.
The mechanism centers on fibroblast activation, angiogenesis, upregulation of collagen and elastin synthesis, and control of the systemic inflammation common in patients seeking a more youthful appearance. Unlike topical treatments, which are limited by the stratum corneum, this protocol delivers bioactive agents mainly by subcutaneous injection to the vascular and cellular structures that support hair, skin, and nails. Because delivery is mostly subcutaneous, self-administration is easier and more practical.
Treat this protocol as a restorative intervention for connective tissue health, not a purely cosmetic procedure.
A naturally occurring copper-binding peptide that modulates collagen synthesis and breakdown. It acts as a feedback signal for tissue remodeling and has strong anti-inflammatory and antioxidant properties that skin regeneration needs.
A pentadecapeptide derived from gastric juice that speeds soft tissue healing. In this protocol its main role is to stimulate angiogenesis (VEGF expression) and improve blood flow to the dermal matrix and hair follicles.
A synthetic fraction of the protein thymosin beta-4 that promotes endothelial cell migration and differentiation. It works with BPC-157 to repair damaged tissue and reduce inflammation at the cellular level.
KPV has significant anti-inflammatory effects, so it is particularly useful for patients with inflammatory dermatoses or a compromised skin barrier. It works with GHK-Cu to strengthen the skin barrier, calm irritation, and reduce visible signs of aging.
A critical coenzyme for poly-ADP-ribose polymerase (PARP) and sirtuin (SIRT1) activation. PARP1 consumes NAD+ to maintain genomic integrity through DNA repair, gene transcription, and chromatin structure. Supplementing NAD+ should quickly improve the age-related decline in energy that comes with low intracellular NAD+.
A long-acting growth hormone releasing hormone (GHRH) analog. The drug affinity complex (DAC) extends its half-life, which makes it a convenient way to raise endogenous growth hormone release. It sustains elevated plasma growth hormone and IGF-1, which drives protein synthesis and systemic tissue repair.
A synthetic tetrapeptide that mimics pineal gland secretion. It addresses cellular senescence by stimulating telomerase activity in fibroblasts, which extends the replicative capacity of skin cells. Epitalon also has a marked effect on the circadian rhythm, improving sleep quality and sleep patterns.
Monthly microneedling plus a daily serum and cream containing GHK-Cu, Argireline, Matrixyl, SNAP-8, and/or tranexamic acid directly supports the systemic GHK-Cu therapy. It often targets surface-level hyperpigmentation, fine lines, and wrinkles.
Needed to keep metallothionein in balance while systemic copper rises with GHK-Cu administration. Zinc competes with copper for absorption and is a critical cofactor for keratin production.
Supplies the amino acid substrate the body needs, specifically glycine, proline, and hydroxyproline. High-dose exogenous collagen makes sure the synthesis pathways upregulated by the peptides have enough raw material.
| Agent | Route | Dose | Frequency | Duration |
|---|---|---|---|---|
| GHK-Cu | Subcutaneous | Start at 0.5 mg daily; titrate up by 0.5 mg every 4–7 days as tolerated, to a maximum of 2.0 mg daily | Daily | |
| Regenerative blend (BPC-157 / TB-500 / KPV) | Subcutaneous | 100 mcg to 600 mcg of each peptide per 100 lbs of body weight (200 mcg per 100 lbs is common for anti-aging) | Daily | Maximum of 12 weeks, followed by a break of at least 4 weeks |
| CJC-1295 with DAC | Subcutaneous | 1 mg | Every 3–4 days | |
| NAD+ (subcutaneous) | Subcutaneous | Start at 25 mg; increase by 25 mg every 2 weeks, to a maximum tolerated dose of 100 mg per dose | Every 3–4 days | |
| Epitalon | Subcutaneous | Up to 10 mg daily | Repeat every 4 months | 5 to 10 days, until a total of 50 mg per cycle is reached |
| Topical application and microneedling | Topical, with microneedling | Daily serum and cream | Microneedling every 4–6 weeks |
Patients can expect a measurable increase in dermal thickness and elasticity from greater collagen I and III production. The angiogenic properties of the regenerative peptides improve microcirculation, which shows up as higher hair follicle density, better skin resilience and repair, and faster nail growth.
Lower oxidative stress markers and better epithelial stem cell efficiency slow the visible effects of aging in skin, especially in areas exposed to more environmental damage. Secondary benefits often include better joint lubrication and soft tissue recovery, because VEGF and growth hormone act systemically.
CJC-1295 with DAC is associated with transient water retention, which can appear as swelling in the extremities or carpal tunnel-like symptoms. This is a physiological adaptation phase, typically made worse by chronic dehydration and/or excessive salt and electrolyte intake. It usually resolves within 3 weeks in men and 6 weeks in women.
GHK-Cu may cause localized pain, redness, or induration after injection, because of its pH and/or an allergic reaction to histidine. Mixing GHK-Cu with phosphate-buffered saline (PBS, pH 7.2–7.4), 2 parts PBS to 1 part GHK-Cu solution, immediately before injection reduces the initial reaction caused by the pH difference. To limit the immune response, combine the GHK-Cu solution with some or all of the peptides in the regenerative blend and use a slow titration schedule.
Skipping zinc supplementation can lead to copper dominance, which may appear as fatigue or mood swings. Monitor serum copper and zinc levels regularly.
Clinical observation suggests initial improvements in skin texture and hydration within 4–6 weeks of adherence. Significant structural changes, such as better hair density and fewer deep wrinkles, typically take 3–6 months of continuous therapy. Counsel patients that results depend on substrate availability, so following the oral supplementation and hydration guidance is essential for the best results.
